Cargando…
A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer
Background: Aberrant glycosylation is significantly related to the occurrence, progression, metastasis, and drug resistance of tumors. It is essential to identify glycosylation and related genes with prognostic value for breast cancer. Objective: We aimed to construct and validate a prognostic model...
Autores principales: | Xu, Shengshan, Liu, Yuchen, Ma, Hansu, Fang, Shuo, Wei, Shoupeng, Li, Xiaoping, Lu, Zhuming, Zheng, Youbin, Liu, Tong, Zhu, Xiaojian, Xu, Dongming, Pan, Yihang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011196/ https://www.ncbi.nlm.nih.gov/pubmed/35432482 http://dx.doi.org/10.3389/fgene.2022.834731 |
Ejemplares similares
-
Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2
por: Xu, Shengshan, et al.
Publicado: (2023) -
A FITM1-Related Methylation Signature Predicts the Prognosis of Patients With Non-Viral Hepatocellular Carcinoma
por: Chen, Jie, et al.
Publicado: (2020) -
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020) -
A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer
por: Li, Xiaoping, et al.
Publicado: (2021) -
Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)